Initial inhaler choice in COPD: real-world evidence

Abstract

@ERSpublications In a real-world cohort (UK's CPRD), initiating inhaled treatment for COPD with ICS/LABA rather than LAMA improves exacerbation rate without significant increases in pneumonia rates in those with peripheral blood eosinophil counts >4% http://bit.ly/2OZpij5